Global Dry Eye Syndrome Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

DUBLIN, March 4, 2022 /PRNewswire/ -- The "Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global dry eye syndrome market reached a value of US$ 4.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 6 Billion by 2027, exhibiting a CAGR of 5.95% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

Various diseases, such as diabetes, thyroid disorders, Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient's blood which adversely affects the tear glands resulting in a rising prevalence of dry eye.

Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being, Akorn Inc., Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd. and Santen Pharmaceutical Co. Ltd.

Key Questions Answered in this Report
1. What was the size of the global dry eye syndrome market in 2021?
2. What is the expected growth rate of the global dry eye syndrome market during 2022-2027?
3. What are the key factors driving the global dry eye syndrome market?
4. What has been the impact of COVID-19 on the global dry eye syndrome market?
5. What is the breakup of the global dry eye syndrome market based on the disease type?
6. What is the breakup of the global dry eye syndrome market based on the drug type?
7. What is the breakup of the global dry eye syndrome market based on the product?
8. What is the breakup of the global dry eye syndrome market based on the distribution channel?
9. What are the key regions in the global dry eye syndrome market?
10. Who are the key companies/players in the global dry eye syndrome market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Disease Type
5.5 Market Breakup by Drug Type
5.6 Market Breakup by Product
5.7 Market Breakup by Distribution Channels
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Drug Type
7.1 Anti-inflammatory Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Lubricant Eye Drops
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autologous Serum Eye Drops
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Product
8.1 Liquid Drops
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gel
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Liquid Wipes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Ointment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region

11 Global Dry Eye Syndrome Industry: SWOT Analysis

12 Global Dry Eye Syndrome Industry: Value Chain Analysis

13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis

14 Global Dry Eye Syndrome Industry: Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis

15 Manufacturing Process
15.1 Product Overview
15.2 Raw Material Requirements
15.3 Manufacturing Process
15.4 Key Success and Risk Factors

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Akorn, Inc.
16.3.2 Alimera Science
16.3.3 Allergan plc.
16.3.4 Auven Therapeutics
16.3.5 Bausch + Lomb
16.3.6 GlaxoSmithKline plc
16.3.7 Nicox S.A.
16.3.8 Novartis AG
16.3.9 Otsuka Holdings Co., Ltd.
16.3.10 Santen Pharmaceutical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/2204xu

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets